Let’s Not Repeat Canada’s Healthcare Mistakes
Newsmax | Sally C. Pipes
August 5, 2021
Even before the COVID-19 pandemic, long delays for treatment were a fact of life for Canadians. In 2019, the median wait time for specialist care following referral from a general practitioner was nearly 21 weeks, according to the Fraser Institute, a Vancouver think tank. |
|
With FDA approval, more would get COVID-19 vaccine
The Orlando Sentinel | Sally C. Pipes
August 7, 2021
Full approval would boost vaccine uptake in three key ways. First, it’d reassure the one in 10 American adults who are taking a “wait and see” approach to the vaccines. A Kaiser Family Foundation poll published in late June found that, of those wait-and-seers, 67% feared the vaccine “was too new” and that drug companies had cut corners to rush the shots to market. Fifty-seven percent “worried about side effects.”
|
|
Dr. Henry Miller Explains Misguided COVID-19 Protocols
The Lars Larson Show | Henry Miller, M.S., M.D.
August 3, 2021
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to discuss the “swiss cheese” approach to testing, screening, and treating COVID-19 and the impact to civil liberties. Miller and Larson debate the balance needed to react to COVID-19 and the moving target by public health officials.
|
|
Infrastructure bill’s ‘buy American’ provision inflates healthcare costs
The Washington Examiner and MSN | Sally C. Pipes
August 10, 2021
It’s expensive to manufacture PPE in America, largely because we have much higher labor costs than in developing countries. In the United States, it costs 50 cents or more to make an N95 respirator. In China, it costs only 25 cents, according to a recent NPR report.
|
|
|
|
